Rupa & Company Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 12, 2025, 9:25 pm

Quick Insight

Rupa & Company Ltd, a key player in the Textiles – Hosiery/Knitwear industry, currently trades at a price of 206 with a market cap of 1,634 Cr. The company's P/E stands at 20.6, while ROE and ROCE are at 8.39% and 10.9% respectively. With an OPM of 6.65%, the net profit sits at 83 Cr. Notably, promoters hold a significant stake of 73.28%, indicating confidence in the business. However, the low FII and DII holdings at 0.92% and 4.19% respectively could be an area for potential growth. With a healthy P/BV of 1.40x and a comfortable ICR of 7.13x, Rupa & Company Ltd appears fundamentally strong, yet efforts to attract more institutional investors could further propel its growth trajectory.

Competitors of Rupa & Company Ltd

All Competitor Stocks of Rupa & Company Ltd

Quarterly Result

Last Updated: August 20, 2025, 4:20 am

Below is a detailed analysis of the quarterly data for Rupa & Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 183.90 Cr.. The value appears to be declining and may need further review. It has decreased from 415.48 Cr. (Mar 2025) to 183.90 Cr., marking a decrease of 231.58 Cr..
• For Expenses, as of Jun 2025, the value is 171.67 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 369.61 Cr. (Mar 2025) to 171.67 Cr., marking a decrease of 197.94 Cr..
• For Operating Profit, as of Jun 2025, the value is 12.23 Cr.. The value appears to be declining and may need further review. It has decreased from 45.87 Cr. (Mar 2025) to 12.23 Cr., marking a decrease of 33.64 Cr..
• For OPM %, as of Jun 2025, the value is 6.65%. The value appears to be declining and may need further review. It has decreased from 11.04% (Mar 2025) to 6.65%, marking a decrease of 4.39%.
• For Other Income, as of Jun 2025, the value is 3.77 Cr.. The value appears to be declining and may need further review. It has decreased from 4.32 Cr. (Mar 2025) to 3.77 Cr., marking a decrease of 0.55 Cr..
• For Interest, as of Jun 2025, the value is 4.77 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.03 Cr. (Mar 2025) to 4.77 Cr., marking a decrease of 0.26 Cr..
• For Depreciation, as of Jun 2025, the value is 3.69 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.58 Cr. (Mar 2025) to 3.69 Cr., marking an increase of 0.11 Cr..
• For Profit before tax, as of Jun 2025, the value is 7.54 Cr.. The value appears to be declining and may need further review. It has decreased from 41.58 Cr. (Mar 2025) to 7.54 Cr., marking a decrease of 34.04 Cr..
• For Tax %, as of Jun 2025, the value is 26.79%. The value appears to be increasing, which may not be favorable. It has increased from 26.43% (Mar 2025) to 26.79%, marking an increase of 0.36%.
• For Net Profit, as of Jun 2025, the value is 5.52 Cr.. The value appears to be declining and may need further review. It has decreased from 30.59 Cr. (Mar 2025) to 5.52 Cr., marking a decrease of 25.07 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.69. The value appears to be declining and may need further review. It has decreased from 3.85 (Mar 2025) to 0.69, marking a decrease of 3.16.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:10 pm

Growth

Last Updated: September 5, 2025, 1:10 pm

Balance Sheet

Last Updated: September 10, 2025, 2:24 pm

Below is a detailed analysis of the balance sheet data for Rupa & Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,010.00 Cr.. The value appears strong and on an upward trend. It has increased from 950.00 Cr. (Mar 2024) to 1,010.00 Cr., marking an increase of 60.00 Cr..
• For Borrowings, as of Mar 2025, the value is 238.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 235.00 Cr. (Mar 2024) to 238.00 Cr., marking an increase of 3.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 256.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 253.00 Cr. (Mar 2024) to 256.00 Cr., marking an increase of 3.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,512.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,446.00 Cr. (Mar 2024) to 1,512.00 Cr., marking an increase of 66.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 241.00 Cr.. The value appears to be declining and may need further review. It has decreased from 244.00 Cr. (Mar 2024) to 241.00 Cr., marking a decrease of 3.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 27.00 Cr., marking an increase of 27.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,244.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,202.00 Cr. (Mar 2024) to 1,244.00 Cr., marking an increase of 42.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,512.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,446.00 Cr. (Mar 2024) to 1,512.00 Cr., marking an increase of 66.00 Cr..

Notably, the Reserves (1,010.00 Cr.) exceed the Borrowings (238.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Rupa & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 10.47. This value is within the healthy range. It has increased from 8.77 (Mar 24) to 10.47, marking an increase of 1.70.
• For Diluted EPS (Rs.), as of Mar 25, the value is 10.47. This value is within the healthy range. It has increased from 8.77 (Mar 24) to 10.47, marking an increase of 1.70.
• For Cash EPS (Rs.), as of Mar 25, the value is 12.28. This value is within the healthy range. It has increased from 10.61 (Mar 24) to 12.28, marking an increase of 1.67.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 127.78. It has increased from 120.31 (Mar 24) to 127.78, marking an increase of 7.47.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 127.78. It has increased from 120.31 (Mar 24) to 127.78, marking an increase of 7.47.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 155.64. It has increased from 152.77 (Mar 24) to 155.64, marking an increase of 2.87.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 18.61. This value is within the healthy range. It has increased from 16.81 (Mar 24) to 18.61, marking an increase of 1.80.
• For PBIT / Share (Rs.), as of Mar 25, the value is 16.79. This value is within the healthy range. It has increased from 14.96 (Mar 24) to 16.79, marking an increase of 1.83.
• For PBT / Share (Rs.), as of Mar 25, the value is 14.18. This value is within the healthy range. It has increased from 11.89 (Mar 24) to 14.18, marking an increase of 2.29.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 10.46. This value is within the healthy range. It has increased from 8.76 (Mar 24) to 10.46, marking an increase of 1.70.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 10.46. This value is within the healthy range. It has increased from 8.76 (Mar 24) to 10.46, marking an increase of 1.70.
• For PBDIT Margin (%), as of Mar 25, the value is 11.95. This value is within the healthy range. It has increased from 11.00 (Mar 24) to 11.95, marking an increase of 0.95.
• For PBIT Margin (%), as of Mar 25, the value is 10.78. This value is within the healthy range. It has increased from 9.79 (Mar 24) to 10.78, marking an increase of 0.99.
• For PBT Margin (%), as of Mar 25, the value is 9.11. This value is below the healthy minimum of 10. It has increased from 7.78 (Mar 24) to 9.11, marking an increase of 1.33.
• For Net Profit Margin (%), as of Mar 25, the value is 6.72. This value is within the healthy range. It has increased from 5.73 (Mar 24) to 6.72, marking an increase of 0.99.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.72. This value is below the healthy minimum of 8. It has increased from 5.73 (Mar 24) to 6.72, marking an increase of 0.99.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.18. This value is below the healthy minimum of 15. It has increased from 7.28 (Mar 24) to 8.18, marking an increase of 0.90.
• For Return on Capital Employeed (%), as of Mar 25, the value is 12.73. This value is within the healthy range. It has increased from 12.02 (Mar 24) to 12.73, marking an increase of 0.71.
• For Return On Assets (%), as of Mar 25, the value is 5.51. This value is within the healthy range. It has increased from 4.82 (Mar 24) to 5.51, marking an increase of 0.69.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 0.23 (Mar 24) to 0.22, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. It has decreased from 0.85 (Mar 24) to 0.83, marking a decrease of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 2.62. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.62.
• For Quick Ratio (X), as of Mar 25, the value is 1.65. This value is within the healthy range. It has decreased from 1.69 (Mar 24) to 1.65, marking a decrease of 0.04.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 4. It has increased from 1.14 (Mar 24) to 1.38, marking an increase of 0.24.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 34.19 (Mar 24) to 0.00, marking a decrease of 34.19.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 28.23 (Mar 24) to 0.00, marking a decrease of 28.23.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 65.81 (Mar 24) to 0.00, marking a decrease of 65.81.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 71.77 (Mar 24) to 0.00, marking a decrease of 71.77.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 7.13. This value is within the healthy range. It has increased from 6.48 (Mar 24) to 7.13, marking an increase of 0.65.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.01. This value is within the healthy range. It has increased from 4.56 (Mar 24) to 5.01, marking an increase of 0.45.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,453.77. It has decreased from 1,900.06 (Mar 24) to 1,453.77, marking a decrease of 446.29.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 1.56 (Mar 24) to 1.17, marking a decrease of 0.39.
• For EV / EBITDA (X), as of Mar 25, the value is 9.81. This value is within the healthy range. It has decreased from 14.19 (Mar 24) to 9.81, marking a decrease of 4.38.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 1.56 (Mar 24) to 1.15, marking a decrease of 0.41.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 65.80 (Mar 24) to 0.00, marking a decrease of 65.80.
• For Price / BV (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has decreased from 1.98 (Mar 24) to 1.40, marking a decrease of 0.58.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 1.56 (Mar 24) to 1.15, marking a decrease of 0.41.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness